ARCX · AMLP
-0.63% · -$0.3300 · Vol Not reported
Live · updated 13:58:01 ET
AMLP

Alerian MLP ETF

$52.05
Card
Relationship Map

Follow $AMLP

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $AMLP by email

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for AMLP until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is AMLP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Alerian MLP ETF
Listed since
2010
Country
US
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$52.53
Day high
$52.59
Day low
$51.55
Previous close
$52.38
52W high
$56.19
-7.37% from high
52W low
$45.45
61% of range
Beta
-0.29
Shares out
240.7M
Avg volume
1.2M
VWAP
$52.38
Last session
Price history computed in-house
1W
-1.57%
1M
-5.88%
3M
-3.66%
1Y
+13.50%
YTD
+10.70%
SMA 50 $54.36 · below
SMA 200 $52.57 · below
52W position 61%

AMLP overview

Financials
Company financial statements are not applicable for AMLP.
Public disclosures

Congress activity in AMLP

5 filers · 3 buys · 5 sells (0 labeled S (partial)) · Mar 18, 2014 to Sep 1, 2023 · House 7 / Senate 1

All available history · Latest 2 of 8 lines · Read Oct 15, 2026, 5:58 PM UTC

Federal contracts

AMLP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AMLP in this window.
Lobbying spend

AMLP lobbying filings, year to date.

Registered lobbying filings matched to Alerian MLP ETF.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AMLP in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for AMLP.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.